|
US9187452B1
|
|
Method for preparing nilotinib
|
|
JP2014037385A
|
|
Maxacalcitol in new crystalline form
|
|
DE102012106786A1
|
|
Process for the preparation of poly (allylamine) hydrochloride and derivatives thereof
|
|
JP2011157326A
|
|
Maxacalcitol intermediate and process for producing the same
|
|
US2009318722A1
|
|
Paricalcitol intermediates
|
|
US2009275768A1
|
|
Preparation of Paricalcitol
|
|
CN101845024A
|
|
Compound for preparing montelukast sodium
|
|
CN101817818A
|
|
Compound used for preparing montelukast sodium
|
|
CN101323589A
|
|
Preparation of novel compound and montelukast sodium
|
|
CN101255145A
|
|
Method for preparing mycophenolate mofetil
|
|
DE102007061630A1
|
|
New compounds and production of montelukast sodium
|
|
US7491712B1
|
|
Process for preparation of paricalcitol and intermediates thereof
|
|
CN101200442A
|
|
Method for preparing [1-(mercapto methyl) cyclopropyl] acetate and derivatives thereof
|
|
US2008188653A1
|
|
Process for Preparation of Mycophenolate Mofetil
|
|
US2008177081A1
|
|
Process for Preparation of Anastrozole
|
|
US7271268B1
|
|
Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives
|
|
US2008097104A1
|
|
Compounds and preparation for montelukast sodium
|
|
TW200714580A
|
|
Process for preparing vitamin D analogs
|
|
CN1948283A
|
|
Preparation method of vitamin D derivative
|
|
CN1876828A
|
|
Separation and isomerization method for vitamin D derivative isomer
|
